Martin Edwards - Jan 3, 2022 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Director
Signature
/s/ Tracy Herson, attorney-in-fact
Stock symbol
RETA
Transactions as of
Jan 3, 2022
Transactions value $
$3,210
Form type
4
Date filed
1/5/2022, 03:02 PM
Previous filing
Oct 4, 2021
Next filing
Apr 29, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Award $1.61K +59 $27.32* 59 Jan 3, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Stock Option (right to buy) Award $1.6K +99 $16.14* 99 Jan 3, 2022 Class A common stock 99 $27.32 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares represent Restricted Stock Units (RSU), which vest on June 8, 2022, subject to continued service through the vesting date.
F2 These RSUs were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $1,612.50.
F3 The options vest in 2 equal installments on March 10, 2022 and June 10, 2022, subject to continued service through each vesting date.
F4 These options were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $1,612.50.